1-anilino-8-naphthalenesulfonate has been researched along with Polycystic Ovarian Syndrome in 8 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease is emerging as the most common cause of chronic liver disease worldwide." | 2.58 | Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics. ( Bernstein, DE; Lim, HW, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, HW | 1 |
| Bernstein, DE | 1 |
| Celik, N | 1 |
| Aydin, S | 1 |
| Ugur, K | 1 |
| Yardim, M | 1 |
| Acet, M | 1 |
| Yavuzkir, S | 1 |
| Sahin, İ | 1 |
| Celik, O | 1 |
| Seow, KM | 1 |
| Tsai, YL | 1 |
| Hwang, JL | 1 |
| Hsu, WY | 1 |
| Ho, LT | 1 |
| Juan, CC | 1 |
| Wild, RA | 1 |
| Diamanti-Kandarakis, E | 2 |
| Piperi, C | 2 |
| Alexandraki, K | 2 |
| Katsilambros, N | 1 |
| Kouroupi, E | 1 |
| Papailiou, J | 1 |
| Lazaridis, S | 1 |
| Koulouri, E | 1 |
| Kandarakis, HA | 1 |
| Douzinas, EE | 1 |
| Creatsas, G | 1 |
| Kalofoutis, A | 1 |
| Katsikis, I | 1 |
| Panidis, D | 1 |
| Rydén, M | 1 |
| Jocken, J | 1 |
| van Harmelen, V | 1 |
| Dicker, A | 1 |
| Hoffstedt, J | 1 |
| Wirén, M | 1 |
| Blomqvist, L | 1 |
| Mairal, A | 1 |
| Langin, D | 1 |
| Blaak, E | 1 |
| Arner, P | 1 |
| Pirwany, IR | 1 |
| Fleming, R | 1 |
| Greer, IA | 1 |
| Packard, CJ | 1 |
| Sattar, N | 1 |
2 reviews available for 1-anilino-8-naphthalenesulfonate and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics.
Topics: Acyltransferases; Asian People; Black or African American; Diabetes Mellitus, Type 2; Female; Hispan | 2018 |
Dyslipidemia in PCOS.
Topics: Androgens; Animals; Apolipoproteins; Dyslipidemias; Female; Humans; Lipase; Lipoproteins, LDL; Polyc | 2012 |
1 trial available for 1-anilino-8-naphthalenesulfonate and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Topics: Adult; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Case-Control Studies; Diet; Drug Adminis | 2007 |
5 other studies available for 1-anilino-8-naphthalenesulfonate and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Patatin-like phospholipase domain containing 3-gene (adiponutrin), preptin, kisspeptin and amylin regulates oocyte developmental capacity in PCOS.
Topics: Adult; Case-Control Studies; Female; Humans; Insulin-Like Growth Factor II; Islet Amyloid Polypeptid | 2018 |
Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome.
Topics: Adipose Tissue; Adult; CD36 Antigens; Fatty Acids, Nonesterified; Female; Humans; Insulin Resistance | 2009 |
Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome.
Topics: Absorption; Adult; Androgens; Case-Control Studies; Diet; Enzyme Inhibitors; Female; Glycation End P | 2006 |
Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis.
Topics: Adipocytes; Adult; Cohort Studies; Down-Regulation; Female; Glycerol; Humans; Lipase; Lipolysis; Mes | 2007 |
Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
Topics: Adult; Anticoagulants; Biomarkers; Body Constitution; Case-Control Studies; Cholesterol, LDL; Choles | 2001 |